Clinical Study
Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection
Table 1
Baseline characteristics of patients.
| | Adenoma positive | Percent | Adenoma negative | Percent | p value | | | (%) | | (%) |
| Mean age | 62.6 | | 55.8 | | <0.0001 | Sex | | | | | | Male | 114 | 52 | 268 | 36 | Ref | Female | 102 | 47 | 459 | 63 | <0.0002 | Race | | | | | | Hispanic | 132 | 61 | 490 | 67 | Ref | African American | 41 | 19 | 106 | 14 | 0.1 | Others | 43 | 20 | 129 | 18 | <0.29 | Chronic PPI use | | | | | | Yes | 131 | 61 | 499 | 68 | Ref | No | 85 | 39 | 228 | 31 | <0.02 | H. pylori infection | | | | | | Yes | 127 | 58.8 | 363 | 50 | Ref | No | 89 | 41 | 364 | 50 | <0.022 | Triple therapy + chronic PPI | 38 | 30 | 198 | 54 | Ref | Triple therapy alone | 89 | 70 | 165 | 45 | <0.00003 |
|
|